Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
NK Cells Plus ICI for SCLC Maintenance
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- Status
- RECRUITING
- Phase
- NA
SMARCA4/2 Inhibitor for POU2F3-Positive SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Status
- RECRUITING
- Phase
- PHASE1
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy
- Status
- COMPLETED
- Phase
- NA
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SYS6090 Combination Therapy in Advanced Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Tarlatamab for SCLC Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2